Albany Molecular Research, Inc. (AMRI) Announces Third Quarter 2013 Results and Raises Full Year EPS Guidance
Published: Nov 06, 2013
ALBANY, N.Y., Nov. 6, 2013 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter ended September 30, 2013.
Financial highlights for the third quarter include:
-- Adjusted diluted earnings per share of $0.13, compared to $0.00 in the prior-year period
Help employers find you! Check out all the jobs and post your resume.